Searched for
BIOPHARMA AND HEALTHCARE SUMMIT
Bio-E3 policy will usher in bio-revolution in India: Jitendra SinghThe government's Bio-E3 policy aims to position India as a global bio-economy leader, similar to the IT revolution in the West. Launched la...- India emerging as favourable destination to conduct global clinical trials: ReportThe joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at...
- US pharma industry seeks R&D policy for India's pharmaceutical sectorBased out of Boston, the USAIC for the last 16 years has been organising the India-US health care summit which is attended by the who's who...
- Pfizer CEO says India vaccine nod is near, but official hints at indemnity hurdle“I hope very soon we will finalise an agreement with the government,” Bourla said at a virtual event organised by USA-India Chamber of Comm...
- Top government officials, leaders from industry, academicians to take part in India-US Biopharma and Healthcare SummitNITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...
- India scaling up production of active pharmaceutical ingredients: Amitabh KantSpeaking at the 14th Annual BioPharma and Healthcare Summit, the NITI Aayog CEO said India is now gearing up for innovation in its pharmace...
- Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...
- PM Modi's action plan to combat coronavirus with SAARC leaders lauded: USAICIn a video-conference of SAARC members on Sunday, Prime Minister Modi proposed setting up a COVID-19 emergency fund with India committing U...
- 'Indian IP and liabilities law barrier to pharma R&D investment'India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that preve...
- India to unveil new drug policy: OfficialsA team of Indian officials led by G N Singh, Drug Controller General of India, said a set of new procedures to facilitate clinical trials a...
- Time for India to be innovator nation in bio-pharmaceuticals: Expert"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."
- Time for India to be innovator nation in bio-pharma: ExpertThis will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...
- India's health and biopharma sector deserve more attentionIndia's health and innovative and biopharma sector deserves better attention from the government to help realise its full potential
- US pharma companies want dialogue with India on intellectual property rightsTop executives of American pharma companies favour "dialogue" with India and "not confrontation" to address their concernson key issues lik...
- Policy, infrastructure main hurdles in Indian pharma R&D: ReportThe McKinsey report commissioned by the US-India Chamber of Commerce would be released at the US-India BioPharma and Healthcare Summit 2013...
- 'India has potential to be global hub of bio-pharma sector'Noting that India has the ability to be a "global hub" in the bio-pharma and healthcare sector, industry leaders have said that steps need ...
- India to establish Technology Acquisition FundAiming to acquire technologies that have been developed and which can be commercialised to put for public good, the Indian Government is pl...
- India can become innovation hub for bio-pharma: BCG reportEmerging markets will drive 70% of growth in the pharma industry and India will require supportive policies to leverage the BioPharma.
- Indian healthcare market to grow despite slowdown: McKinseyNotwithstanding the current global economic crisis, India's pharmaceutical industry and its health care market are expected to grow rapidly...
- ‘India has potential to be the pharma R&D leader’In the artistic environs of her office on the 10th floor of the plush Nicholas Piramal Tower, Swati Piramal, director (strategic alliances ...
Load More
